| 2014-11-18 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, Chief Business Officer | 20,000 0.0271% | $90.67 | $1.81M | +16.54% | |
| 2014-08-18 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, Chief Business Officer | 27,000 0.0354% | $67.34 | $1.82M | +52.39% | |
| 2014-05-19 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, Chief Business Officer | 27,000 0.0353% | $57.83 | $1.56M | +57.82% | |
| 2014-02-19 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, Chief Business Officer | 40,800 0.0609% | $80.06 | $3.27M | -8.2% | |
| 2013-11-13 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, Chief Business Officer | 27,000 0.0286% | $34.67 | $936,167 | +24.52% | |
| 2013-05-28 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP and Chief Business Officer | 10,000 0.0101% | $18.55 | $185,500 | +93.71% | |
| 2013-02-08 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, Chief Business Officer | 10,000 0.0109% | $16.05 | $160,500 | +95.65% | |
| 2012-02-21 | Alnylam Pharmaceuticals, Inc. ALNY | SVP, Chief Business Officer | 1,860 0.0036% | $10.75 | $19,995 | +41.4% |